Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
Clinical trial NCT03874325 · TERMINATED
Trial details
- NCT number
- NCT03874325
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2020-11-15
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.